IGFBP2 and systemic lupus erythematosus: And, a blockade of IGFBP2 elevated the ratio of Tregs inhibits the proliferation and activation of CD4+ T cells, thereby achieving the possibility of inhibiting the progression of lupus (Fig. 7A) (P < 0.05).